Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.

Danielle Crawley, Sharmistha Ghosh, Saranya Ravindra et al.|Journal of Clinical Oncology|2020

Cited by 1